CD274 and neoplasm: The PD-L1 positivity rate in the CHOICE study was 23.1% using H-score ≥50, or 63.9% using >1% tumor cell positive as a cutoff, which is consistent with what was reported in the literature on the Western population (Fig. 6a–f).